NCT06285994

Brief Summary

High frequency jet ventilation (HFJV) has been introduced in 1967 as technique allowing ventilation with simultaneous access to the airway for bronchoscopy. Continuous improvement in the technique has led to a large use during interventional bronchoscopy, especially in large centers. However, complications occuring during the use of HFJV are poorly known. In this retrospective cohort study, the charts of all patients who had a bronchoscopy with the use of HFJV between 2019 and 2023 in our hospital will be analyzed. Primary outcome will the description of all complications during HFJV. Complications are defined as:

  • Hypoxia: SpO2 \< 90% for 1 min
  • Severe hypoxia: SpO2 \< 85% for 1 min
  • Hemodynamic instability, defined as Arterial pressure \< 90/60
  • Cardiac arrhythmia
  • Laryngospasm or bronchospasm
  • Barotrauma or volutrauma
  • Need for ICU admission A model predicting the risk for developing any complication will be developped using 2 mathematical methods:
  • a multivariate analysis
  • a data mining approach For both approaches, the following variables will be included in the model:
  • Age
  • Gender
  • Weight
  • Height
  • BMI
  • Smoking
  • Alcohol consumption
  • Consumption of Other drugs
  • ASA class
  • Obstructive pulmonary disease
  • Restrictive lung disease
  • COPD status (1, 2, 3, 4)
  • Interstitial lung disease
  • Lung tumor
  • Trachea location
  • Carina location
  • Bronchial location
  • Pulmonary or tracheal stenosis
  • Presence of stridor
  • Severe stenosis (\< 6 mm)
  • Baseline SpO2 (pre-intervention)
  • Pre-intervention oxygen requirement Procedure
  • Duration (min)
  • Stent placement
  • Dilation
  • Laser treatment
  • Length of hospital stay Lung function tests
  • FEV1 (forced expiratory volume)
  • VC (Vital Capacity)
  • FEV1/VC (Tiffeneau ratio)
  • CPT (total lung capacity)
  • DLCO (carbon monoxide diffusion)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,385

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

March 3, 2024

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 19, 2024

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

May 21, 2025

Status Verified

May 1, 2025

Enrollment Period

16 days

First QC Date

February 12, 2024

Last Update Submit

May 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Occurence of complications

    The occurence (%) of complications of HFJV will be analyzed. Definition of complications is one or more of the following events: * Hypoxia: SpO2 \< 90% for 1 min (%) * Severe hypoxia: SpO2 \< 85% for 1 min (%) * Hemodynamic instability, defined as Arterial pressure \< 90/60 (%) * Cardiac arrhythmia (%) * Laryngospasm or bronchospasm (%) * Barotrauma or volutrauma (%) * Need for ICU admission (%) Complications will be reported as overall complications (%) defined as the occurence of one or more of the listed events. Frequency of single events will be reported separately (%). Descriptive statistics ( %, mean, standard deviation, median, interquartile range) will be used as appropriate.

    6 hours

Secondary Outcomes (1)

  • Prediction model of complications

    6 hours

Study Arms (1)

HFJV

All patients who underwent bronchoscopy with the use of high frequency jet ventilation between January 1st 2019 and december 31st 2023.

Procedure: High frequency jet ventilation

Interventions

Use of high frequency jet ventilation during bronchoscopy

HFJV

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who underwent a bronchoscopy with the use of high frequency jet ventilation

You may qualify if:

  • All patients who underwent a bronchoscopy with the use of high frequency jet ventilation between January 1st, 2019 and December 31st, 2023 at Erasme University Hospital, Brussels

You may not qualify if:

  • Incomplete medical chart
  • Patient who expressed their opposition to the use of their medical data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Universitaire de Bruxelles - Hôpital erasme

Brussels, 1070, Belgium

Location

Related Publications (8)

  • Aravena C, Mehta AC, Almeida FA, Lamb C, Maldonado F, Gildea TR. Innovation in rigid bronchoscopy-past, present, and future. J Thorac Dis. 2023 May 30;15(5):2836-2847. doi: 10.21037/jtd-22-779. Epub 2023 Apr 25.

    PMID: 37324083BACKGROUND
  • Putz L, Mayne A, Dincq AS. Jet Ventilation during Rigid Bronchoscopy in Adults: A Focused Review. Biomed Res Int. 2016;2016:4234861. doi: 10.1155/2016/4234861. Epub 2016 Oct 26.

    PMID: 27847813BACKGROUND
  • Poling HE, Wolfson B, Siker ES. A technique of ventilation during laryngoscopy and bronchoscopy. Br J Anaesth. 1975 Mar;47(3):382-4. doi: 10.1093/bja/47.3.382.

    PMID: 1138745BACKGROUND
  • Klain M, Smith RB. High frequency percutaneous transtracheal jet ventilation. Crit Care Med. 1977 Nov-Dec;5(6):280-7. doi: 10.1097/00003246-197711000-00007. No abstract available.

    PMID: 338247BACKGROUND
  • Hautmann H, Gamarra F, Henke M, Diehm S, Huber RM. High frequency jet ventilation in interventional fiberoptic bronchoscopy. Anesth Analg. 2000 Jun;90(6):1436-40. doi: 10.1097/00000539-200006000-00034.

    PMID: 10825336BACKGROUND
  • Ost DE, Ernst A, Grosu HB, Lei X, Diaz-Mendoza J, Slade M, Gildea TR, Machuzak M, Jimenez CA, Toth J, Kovitz KL, Ray C, Greenhill S, Casal RF, Almeida FA, Wahidi M, Eapen GA, Yarmus LB, Morice RC, Benzaquen S, Tremblay A, Simoff M; AQuIRE Bronchoscopy Registry. Complications Following Therapeutic Bronchoscopy for Malignant Central Airway Obstruction: Results of the AQuIRE Registry. Chest. 2015 Aug;148(2):450-471. doi: 10.1378/chest.14-1530.

    PMID: 25741903BACKGROUND
  • Goudra BG, Singh PM, Borle A, Farid N, Harris K. Anesthesia for Advanced Bronchoscopic Procedures: State-of-the-Art Review. Lung. 2015 Aug;193(4):453-65. doi: 10.1007/s00408-015-9733-7. Epub 2015 Apr 29.

    PMID: 25921014BACKGROUND
  • Fernandez-Bustamante A, Ibanez V, Alfaro JJ, de Miguel E, German MJ, Mayo A, Jimeno A, Perez-Cerda F, Escribano PM. High-frequency jet ventilation in interventional bronchoscopy: factors with predictive value on high-frequency jet ventilation complications. J Clin Anesth. 2006 Aug;18(5):349-56. doi: 10.1016/j.jclinane.2005.12.011.

    PMID: 16905080BACKGROUND

MeSH Terms

Interventions

High-Frequency Jet Ventilation

Intervention Hierarchy (Ancestors)

High-Frequency VentilationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 12, 2024

First Posted

February 29, 2024

Study Start

March 3, 2024

Primary Completion

March 19, 2024

Study Completion

February 1, 2025

Last Updated

May 21, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations